volume 21 issue 9 pages 1096-1112

Isatin: A Scaffold with Immense Biodiversity

Priyobrata Nath 1
Agnish Mukherjee 1
Sougata Mukherjee 1
Sabyasachi Banerjee 1
Samarpita Das 1
Subhasis Banerjee 1
1
 
Department of Pharmaceutical Chemistry, Gupta College of Technological Sciences, Ashram More, G.T. Road, Asansol 713301 West Bengal,India
Publication typeJournal Article
Publication date2020-11-26
scimago Q2
wos Q3
SJR0.662
CiteScore8.5
Impact factor3.3
ISSN13895575, 18755607
Drug Discovery
General Medicine
Pharmacology
Abstract

Isatin is an endogenous and a significant category of fused heterocyclic components and has widely been a part of several potential biologically useful synthetics. Since its discovery, tons of research work has been conducted with respect to the synthesis, chemical properties, and biological and industrial applications. It contains an indole nucleus having both lactam and keto moiety, which, while being a part of a molecular framework, exerted several biological effects, viz.; anti-microbial, anti-tubercular, anticonvulsant, anti-cancer, etc. Isatin derivatives are synthetically significant substrates, which can be utilized for the synthesis of huge diversified chemical entities of which few members emerged as drugs. The reason for this review is to provide extensive information pertaining to the chemistry and its significance in altering several pathological states of isatin and its derivatives. A Structure-Activity Relationship study thus developed through a gamut of scientific information indicates the importance of mostly electron-withdrawing groups, halogens, nitro, alkoxy, and, to a minor extent, groups with positive inductive effects, such as methyl at position 1, 5, 6 and 7 of isatin in alleviating several clinical conditions. It is also observed from the survey that the presence of two oxo groups at positions 2 and 3 sometimes becomes insignificant as a fusion with a heterocycle at these positions resulted in a biologically relevant compound.

Found 
Found 

Top-30

Journals

1
2
3
Antibiotics
3 publications, 7.69%
Medicinal Chemistry Research
2 publications, 5.13%
Frontiers in Pharmacology
2 publications, 5.13%
Molecules
2 publications, 5.13%
Polycyclic Aromatic Compounds
2 publications, 5.13%
Archiv der Pharmazie
2 publications, 5.13%
Russian Journal of General Chemistry
2 publications, 5.13%
Current Topics in Medicinal Chemistry
1 publication, 2.56%
Frontiers in Molecular Biosciences
1 publication, 2.56%
Arabian Journal of Chemistry
1 publication, 2.56%
Journal of Molecular Structure
1 publication, 2.56%
RSC Medicinal Chemistry
1 publication, 2.56%
ACS Omega
1 publication, 2.56%
Medicinal Chemistry
1 publication, 2.56%
Coordination Chemistry Reviews
1 publication, 2.56%
Organics
1 publication, 2.56%
Medicine (United States)
1 publication, 2.56%
Applied Microbiology
1 publication, 2.56%
Applied Biological Chemistry
1 publication, 2.56%
Synthesis
1 publication, 2.56%
Molecular Physics
1 publication, 2.56%
Journal of Heterocyclic Chemistry
1 publication, 2.56%
Mendeleev Communications
1 publication, 2.56%
Tetrahedron
1 publication, 2.56%
Chemistry - An Asian Journal
1 publication, 2.56%
Pharmacological Research - Reports
1 publication, 2.56%
Archives of Biochemistry and Biophysics
1 publication, 2.56%
Discover Chemistry
1 publication, 2.56%
ChemistrySelect
1 publication, 2.56%
Journal of Organic Chemistry
1 publication, 2.56%
1
2
3

Publishers

1
2
3
4
5
6
7
MDPI
7 publications, 17.95%
Elsevier
6 publications, 15.38%
Wiley
5 publications, 12.82%
Springer Nature
4 publications, 10.26%
Frontiers Media S.A.
3 publications, 7.69%
Taylor & Francis
3 publications, 7.69%
Bentham Science Publishers Ltd.
2 publications, 5.13%
American Chemical Society (ACS)
2 publications, 5.13%
Pleiades Publishing
2 publications, 5.13%
King Saud University
1 publication, 2.56%
Royal Society of Chemistry (RSC)
1 publication, 2.56%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 2.56%
Georg Thieme Verlag KG
1 publication, 2.56%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 2.56%
1
2
3
4
5
6
7
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
39
Share
Cite this
GOST |
Cite this
GOST Copy
Nath P. et al. Isatin: A Scaffold with Immense Biodiversity // Mini-Reviews in Medicinal Chemistry. 2020. Vol. 21. No. 9. pp. 1096-1112.
GOST all authors (up to 50) Copy
Nath P., Mukherjee A., Mukherjee S., Banerjee S., Das S., Banerjee S. Isatin: A Scaffold with Immense Biodiversity // Mini-Reviews in Medicinal Chemistry. 2020. Vol. 21. No. 9. pp. 1096-1112.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.2174/2211536609666201125115559
UR - https://doi.org/10.2174/2211536609666201125115559
TI - Isatin: A Scaffold with Immense Biodiversity
T2 - Mini-Reviews in Medicinal Chemistry
AU - Nath, Priyobrata
AU - Mukherjee, Agnish
AU - Mukherjee, Sougata
AU - Banerjee, Sabyasachi
AU - Das, Samarpita
AU - Banerjee, Subhasis
PY - 2020
DA - 2020/11/26
PB - Bentham Science Publishers Ltd.
SP - 1096-1112
IS - 9
VL - 21
PMID - 33238872
SN - 1389-5575
SN - 1875-5607
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2020_Nath,
author = {Priyobrata Nath and Agnish Mukherjee and Sougata Mukherjee and Sabyasachi Banerjee and Samarpita Das and Subhasis Banerjee},
title = {Isatin: A Scaffold with Immense Biodiversity},
journal = {Mini-Reviews in Medicinal Chemistry},
year = {2020},
volume = {21},
publisher = {Bentham Science Publishers Ltd.},
month = {nov},
url = {https://doi.org/10.2174/2211536609666201125115559},
number = {9},
pages = {1096--1112},
doi = {10.2174/2211536609666201125115559}
}
MLA
Cite this
MLA Copy
Nath, Priyobrata, et al. “Isatin: A Scaffold with Immense Biodiversity.” Mini-Reviews in Medicinal Chemistry, vol. 21, no. 9, Nov. 2020, pp. 1096-1112. https://doi.org/10.2174/2211536609666201125115559.